Efficacy and safety of mesenchymal stromal cells of bone marrow in patients with refractory forms Crohn's disease
- Autores: Knyazev O.V1, Parfenov A.I1, Shcherbakov P.L1, Ruchkina I.N1, Khomeriki S.G1, Konoplyannikov A.G2
-
Afiliações:
- Central Research Institute of Gastroenterology, Moscow
- Medical Radiological Research Center, Obninsk
- Edição: Volume 8, Nº 1 (2013)
- Páginas: 76-84
- Seção: Articles
- ##submission.dateSubmitted##: 11.01.2023
- ##submission.datePublished##: 15.05.2013
- URL: https://genescells.ru/2313-1829/article/view/121624
- DOI: https://doi.org/10.23868/gc121624
- ID: 121624
Citar
Texto integral
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Texto integral
Sobre autores
O. Knyazev
Central Research Institute of Gastroenterology, Moscow
A. Parfenov
Central Research Institute of Gastroenterology, Moscow
P. Shcherbakov
Central Research Institute of Gastroenterology, Moscow
I. Ruchkina
Central Research Institute of Gastroenterology, Moscow
S. Khomeriki
Central Research Institute of Gastroenterology, Moscow
A. Konoplyannikov
Medical Radiological Research Center, Obninsk
Bibliografia
- Crohn B.B., Ginzburg L., Oppenheimer G.D. Regional ileitis; a pathologic and clinical entity. J. Amer. Med. Assoc. 1932; 99: 1323—9.
- Белоусова Е.А. Реальные и потенциальные возможности лечения рефрактерных форм воспалительных заболеваний кишечника. Рус. мед. журн. 2005; 2: 88—95.
- Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998; 115(1): 182—205.
- Malchow H., Ewe K., Brandes J.W. et al. European cooperative Crohn's disease study (ECCDS): results of drug treatment. Gastroenterology 1984; 86: 249—66.
- Summers R.W., Switz D.M., Sessions J.T. et al. National cooperative Crohn's disease study group: results of drug treatment. Gastroenterology 1979; 77: 847—69.
- Faubion W.A., Loftus E.V., Harmsen W.S. et all. The natural history of corticosteroid therapy for inflammatory bowel disease: a population based study. Gastroenterology 2001; 121: 255—60.
- Breedveld F.C. Therapeutic monoclonal antibodies. Lancet 2000; 355: 735—40.
- Rutgeerts P., Feagan B.G., Lichtenstein G.R. et al. Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease. Gastroenterology 2004; 126: 402—13.
- Wayne G. Overview of stem cell therapy for Crohn's disease. Expert. Opin. Biol. Ther. 2009; 9(7): 841—7.
- Распоряжение Правительства РФ от 28.12.2012 №2580-р «Об утверждении Стратегии развития медицинской науки в РФ на период до 2025 года».
- Chapel A., Bertho J.M., Bensidhoum M. et al. Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. J. Gene Med. 2003; 5: 1028—38.
- Krampera M., Glennie S., Dyson J. et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003; 101: 3722—29.
- Uccelli A., Pistoia V., Moretta L. Mesenchymal stem cells: a new strategy for immunosuppression? Trends Immunol. 2007; 28: 219-26.
- Abdi R., Fiorina P., Adra C.N. et al. Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes. Diabetes 2008; 57: 1759-67.
- Meisel R., Zibert A., Laryea M. et al. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indolamine 2,3-dioxygenase-mediated tryptophan degredation. Blood 2004; 103: 4619-21.
- Rabinovitch A., Suarez-Pinzon W.L. Role of cytokines in the pathogenesis of autoimmune diabetes mellitus. Rev. Endocr. Metab. Disord. 2003; 4(3): 291-9.
- Drakos P.E., Nagler A., Or R. Case of Crohn’s disease in bone marrow transplantation. Am. J. Hematol. 1993; 43: 157-8.
- Molendijk I., Duijvestein M., van der Meulen-de A.E. et al. Immunomodulatory effects of mesenchymal stromal cells in Crohn’s disease. J. Allergy 2012; 2012: 187408.
- Best W.R., Becktel J.M., Singleton J.W. et al. Development of a Crohn’s disease activity index. National Cooperative Crohn’s Disease Study. Gastroenterology 1976; 70(3): 439-40.
- Sandborn W.J, Feagan B.G, Hanauer S.B. et al. А review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn’s disease. Gastroenterology 2002; 122: 512-30.
- Цыб А.Ф., Коноплянников А.Г., Колесникова А.И. и др. Получение и использование в медицине клеточных культур из мезенхимальных стволовых клеток костного мозга человека. Вестник Российской Академии медицинских наук 2004; 59(9): 71- 6.
- Lalu M.M., McIntyre L., Pugliese C. et al. Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS One 2012; 7(10): e47559.
- Oyama Y., Traynor A.E., Barr W. et al. Allogeneic stem cell transplantation for autoimmune diseases: nonmyeloablative conditioning regimens. Bone Marrow Transplant. 2003; 32 Suppl 1: S81-3.